Bnp Paribas Arbitrage, Snc »

X4 Pharmaceuticals shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9k 554 3.42
2025-06-30 $1.2k 636 1.90

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Equity (META)
Apple Equity (AAPL)
Tesla Equity (TSLA)
Amazon.com Equity (AMZN)
iShares Core S&P 500 ETF Fund (IVV)
Broadcom Equity (AVGO)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOGL)
SPDR S&P 500 ETF Trust Fund (SPY)
iShares Russell 2000 ETF Fund (IWM)
Alphabet Equity (GOOG)
Cisco Systems Equity (CSCO)
General Electric Equity (GE)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Stonepine Capital Management
Kingdon Capital Management
Stempoint Capital
Vanguard Group
Boothbay Fund Management
Pale Fire Capital SE
UBS Group
Susquehanna International
Palumbo Wealth Management
Geode Capital Management

View all funds holding X4 Pharmaceuticals